Contributor Disclosures for Kallmann Syndrome and Idiopathic Hypogonadotropic Hypogonadism
Role Name Disclosure Details
Author Nicholas A Tritos, MD, DSc, MMSc, FACE, FACP, Assistant Professor of Medicine, Tufts University School of Medicine; Senior Staff Physician, Department of Endocrinology, Lahey Clinic Medical Center Nothing to discloseDetails
Medical Editor Ghassem Pourmotabbed, MD †, Former Associate Professor, Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Tennessee School of Medicine and Health Science Center Nothing to discloseDetails
Pharmacy Editor Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to discloseDetails
Managing Editor Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, School of Computational Sciences; Principal, Bioinformatics and Computational Biology Program, C/A Informatics, LLC Nothing to discloseDetails
CME Editor Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University Nothing to discloseDetails
Chief Editor George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University Nothing to discloseDetails

eMedicine Code of Ethics
    1. eMedicine.com, Inc, henceforth referred to as eMedicine, is dedicated to providing up-to-date, peer-reviewed medical information. This information may be accessed in various ways; however, the primary delivery portal is the Internet. The free availability of our medical journals online reflects the commitment of eMedicine to disseminate knowledge to the widest possible audience, including individuals, groups, or populations that may not otherwise have access to such medical information.

    2. eMedicine is committed to publishing medical journals of high quality. To achieve this end, all eMedicine topics are reviewed and edited by 4 physicians and a doctor of pharmacy. eMedicine strives to ensure that any claims relating to the benefits of a specific treatment, commercial product, or service are supported by appropriate, balanced evidence. Therefore, each article contains references to sources used when writing the topic and the date when clinical information was last modified.

    3. eMedicine respects and values the sanctity of the physician-patient relationship. Information provided by eMedicine is designed to support, not replace, the relationships that exist among patients and their physicians and other health care providers. Accordingly, eMedicine's authors and editors do not provide patient consultation through email.

    4. eMedicine's owners, staff, authors, editors, and advertisers maintain the confidentiality of the identity of individual patients whose cases may be presented and that of visitors to the eMedicine Web site.

    5. eMedicine is a privately held organization. Advertising by commercial and noncommercial organizations that provide funding, services, or materials for eMedicine activities does not influence medical content. eMedicine's advertising and promotional material is subject to review by the Ethics Committee and is presented to viewers in a manner and context that facilitates differentiation between the advertising and promotional material and the original textual information.

    6. eMedicine does not endorse any medical institution, biomedical technology, or pharmaceutical product. Furthermore, eMedicine requires authors to report any conflict of interest (eg, financial interest in any medical companies, pharmaceutical company funding of topic-related research) and posts such disclosures in each article.


    For further information, contact Lynn Barkley Burnett, EdD, MS, Chair, eMedicine Ethics Committee.






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Nicholas A Tritos

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Ghassem Pourmotabbed, Medical Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Francisco Talavera

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Arthur B Chausmer

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Mark Cooper

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
George T Griffing

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication